rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Cheryl Ann Stouch

EVP & Chief Info Officer

Company insider

Files Form 4 as: EVP & Chief Info Officer, Keenova Therapeutics.

In numbers

Trades disclosed
10
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
31 Jul 2025
Last trade
21 Jul 2026
Last filed
23 Jul 2026

Companies traded

Where they are an officer
Keenova TherapeuticsOfficer · last 21 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
21 Jul 2026filed 23 Jul 2026Keenova TherapeuticsSEC FORM 4 Code F—328filing
21 Jul 2026filed 23 Jul 2026Keenova TherapeuticsSEC FORM 4 Code F—328filing
23 Apr 2026filed 24 Apr 2026Keenova TherapeuticsSEC FORM 4 Code M—1,137filing
23 Apr 2026filed 24 Apr 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—1,137 at $0.00filing
23 Apr 2026filed 24 Apr 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—1,137 at $0.00filing
23 Apr 2026filed 24 Apr 2026Keenova TherapeuticsSEC FORM 4 Code M—1,137filing
25 Feb 2026filed 26 Feb 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—15,936 at $0.00filing
25 Feb 2026filed 26 Feb 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—15,936 at $0.00filing
31 Jul 2025filed 4 Aug 2025Mallinckrodtoption or derivativeSEC FORM 4 Code A—8,514 at $0.00filing
31 Jul 2025filed 4 Aug 2025MallinckrodtSEC FORM 4 Code A—631filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

GOLDENTREE ASSET MANAGEMENT LP10% owner · 10% owner at Keenova Therapeutics, filing Form 4 there in the last year
Susan Ann WilliamsonEVP & Chief Compliance Officer · EVP & Chief Compliance Officer at Keenova Therapeutics, filing Form 4 there in the last year
Tracy BassoEVP & Chro · EVP & Chro at Keenova Therapeutics, filing Form 4 there in the last year
Jon ZinmanDirector · Director at Keenova Therapeutics, filing Form 4 there in the last year
Scott HirschDirector · Director at Keenova Therapeutics, filing Form 4 there in the last year